2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery
- PMID: 36336720
- PMCID: PMC9834364
- DOI: 10.1007/s11695-022-06332-1
2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery
Erratum in
-
Publisher Correction: 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery.Obes Surg. 2023 Jan;33(1):15-16. doi: 10.1007/s11695-022-06369-2. Obes Surg. 2023. PMID: 36445365 Free PMC article. No abstract available.
Abstract
MAJOR UPDATES TO 1991 NATIONAL INSTITUTES OF HEALTH GUIDELINES FOR BARIATRIC SURGERY: Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >35 kg/m2, regardless of presence, absence, or severity of co-morbidities.MBS should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m2.BMI thresholds should be adjusted in the Asian population such that a BMI >25 kg/m2 suggests clinical obesity, and individuals with BMI >27.5 kg/m2 should be offered MBS.Long-term results of MBS consistently demonstrate safety and efficacy.Appropriately selected children and adolescents should be considered for MBS.(Surg Obes Relat Dis 2022; https://doi.org/10.1016/j.soard.2022.08.013 ) © 2022 American Society for Metabolic and Bariatric Surgery. All rights reserved.
Keywords: ASMBS; Criteria; IFSO; Indications; Metabolic and bariatric surgery; Obesity.
© 2022. The Author(s). Published by Elsevier Inc on behalf of American Society for Metabolic & Bariatric Surgery (ASMBS) and Springer Nature on behalf of International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).
Comment in
-
Reply to "New IFSO/ASMBS Indications for Metabolic and Bariatric Surgery? Yes, After Failure of Best Nonsurgical Therapy".Obes Surg. 2023 Aug;33(8):2594-2595. doi: 10.1007/s11695-023-06667-3. Epub 2023 Jun 13. Obes Surg. 2023. PMID: 37308733 No abstract available.
-
New IFSO/ASMBS Indications for Metabolic and Bariatric Surgery? Yes, After Failure of Best Nonsurgical Therapy.Obes Surg. 2023 Aug;33(8):2592-2593. doi: 10.1007/s11695-023-06665-5. Epub 2023 Jun 20. Obes Surg. 2023. PMID: 37338796 No abstract available.
References
-
- Gastrointestinal surgery for severe obesity. Consens Statement 1991;9(1):1–20. - PubMed
-
- World Health Organization (WHO) [monograph on the Internet]. Geneva: World Health Organization; 2002 [cited 2022 Mon D]. Available from: https://www.who.int/publications/i/item/9241562072.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials